Crossmark

A clinical prediction tool for extended-spectrum β-lactamase-producing Enterobacteriaceae urinary tract infection

Published Online: 2022-01-13

Published Print: 2022-12

Authors

Liu, Hui

Qiu, Suishan

Chen, Minghao

Lyu, Jun

Yu, Guangchao

Xue, Lianfang
Funding

Funding for this research was provided by:

Guangdong Provincial Bureau of traditional Chinese Medicine (No. 20201082, No. 20191089)

Guangdong Provincial Hospital Pharmaceutical Research Fund (No. 2020A27)
License Information

Text and Data Mining valid from 2022-01-13

Version of Record valid from 2022-01-13
More Information

Article History

Received: 12 May 2021

Accepted: 4 January 2022

First Online: 13 January 2022

Declarations

:

: This study was approved by the Ethics Committee of the First Affiliated Hospital of Jinan University. This study was carried out in compliance with the Declaration of Helsinki guidelines. Clinical Laboratory concluded that no informed consent was required because the data are anonymized appropriately.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current